Long-term safety and tolerability of bapineuzumab in patients with AD in two phase 3 extension studies - Ivanoiu, A; Pariente, J; Booth, K; Lobello, K; Luscan, G; Hua, L; Lucas, P; Styren, S; Yang, L; Li, D; Black, R S; Brashear, H R; McRae, T (Alzheimers Res Ther, 2016)